PRIMARY PERITONEAL CARCINOMA AFTER PROPHYLACTIC OOPHORECTOMY IN WOMEN WITH A FAMILY HISTORY OF OVARIAN-CANCER - A REPORT OF THE GILDA-RADNER-FAMILIAL-OVARIAN-CANCER-REGISTRY

被引:0
|
作者
PIVER, MS
JISHI, MF
TSUKADA, Y
NAVA, G
机构
[1] Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York
关键词
FAMILIAL OVARIAN CANCER; PERITONEAL CARCINOMA; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. According to previous reports, primary peritoneal carcinoma indistinguishable from primary ovarian adenocarcinoma had developed in five women with a history of familial ovarian cancer who had undergone prophylactic oophorectomy. Methods. The records from the Gilda Radner Familial Ovarian Cancer Registry were reviewed for instances of prophylactic oophorectomy and cases of primary peritoneal carcinoma occurring after prophylactic oophorectomy. Results. From 1981 through July 1992, the Gilda Radner Familial Ovarian Cancer Registry accessioned 931 families (a total of 2221 cases of familial ovarian cancer). Currently, 324 women in these families have undergone prophylactic oophorectomy as a preventive measure against the subsequent development of ovarian cancer. Primary peritoneal carcinoma indistinguishable histologically from primary ovarian adenocarcinoma has developed in six of these women 1-27 years after prophylactic oophorectomy. Conclusions. Based on this finding and other reports of such primary peritoneal carcinoma, a prospective international study is planned. This study will compare the incidence of peritoneal carcinoma in first- or second-degree relatives who underwent prophylactic oophorectomy because of a family history of ovarian cancer with that of those who did not undergo prophylactic oophorectomy.
引用
收藏
页码:2751 / 2755
页数:5
相关论文
共 50 条
  • [31] Platelet counts and venous thromboembolism after splenectomy in women undergoing primary or interval cytoreduction for ovarian, tubal, or primary peritoneal cancer
    Filippova, O. T.
    Kim, S. W.
    Cowan, R. A.
    Iasonos, A.
    Zhou, Q.
    Zivanovic, O.
    Roche, K. Long
    Sonoda, Y.
    Gardner, G. J.
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 98 - 98
  • [32] The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer: Is the evidence strong enough?
    Haldar, Krishnayan
    Crawford, Robin
    GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 148 - 149
  • [33] ASSESSMENT OF RELATIVE RISK OF 2ND PRIMARY TUMORS AFTER OVARIAN-CANCER AND OF THE USEFULNESS OF DOUBLE PRIMARY CASES AS A SOURCE OF MATERIAL FOR GENETIC-STUDIES WITH A CANCER REGISTRY
    SHAH, S
    EVANS, DGR
    BLAIR, V
    BURNELL, LD
    BIRCH, JM
    CANCER, 1993, 72 (03) : 819 - 827
  • [34] But how will I feel afterwards? Changes in quality of life from before to after prophylactic oophorectomy among women at elevated risk for breast and ovarian cancer
    McGregor, Bonnie
    Dolan, Emily D.
    Ceballos, Rachel M.
    Fann, Jesse R.
    Paley, Pamela
    Swisher, Elizabeth M.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S200 - S200
  • [35] Hematologic changes in women with and without infection after splenectomy during primary or interval debulking surgery for ovarian, tubal, or primary peritoneal cancer
    Filippova, O. T.
    Kim, S. W.
    Cowan, R. A.
    Iasonos, A.
    Zhou, Q.
    Zivanovic, O.
    Roche, K. Long
    Sonoda, Y.
    Gardner, G. J.
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 97 - 97
  • [36] The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia
    Zhi L. Teo
    Sarah D. Sawyer
    Paul A. James
    Gillian Mitchell
    Alison H. Trainer
    Geoffrey J. Lindeman
    Kylie Shackleton
    Linda Cicciarelli
    Melissa C. Southey
    Familial Cancer, 2013, 12 : 587 - 595
  • [37] Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view
    Mohr-Sasson, Aya
    Dadon, Tal
    Perri, Tamar
    Rosenblat, Orgad
    Friedman, Eitan
    Korach, Jacob
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (05): : 476 - 479
  • [38] The incidence of PALB2 c.3113G&gt;A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia
    Teo, Zhi L.
    Sawyer, Sarah D.
    James, Paul A.
    Mitchell, Gillian
    Trainer, Alison H.
    Lindeman, Geoffrey J.
    Shackleton, Kylie
    Cicciarelli, Linda
    Southey, Melissa C.
    FAMILIAL CANCER, 2013, 12 (04) : 587 - 595
  • [39] Factors Associated with Altered Long-Term Well-Being After Prophylactic Salpingo-Oophorectomy Among Women at Increased Hereditary Risk for Breast and Ovarian Cancer
    Touboul, Cyril
    Uzan, Catherine
    Ichante, Jean Laurent
    Caron, Olivier
    Dunant, Ariane
    Dauchy, Sarah
    Gouy, Sebastien
    de Paillerets, Brigitte Bressac
    Morice, Philippe
    Delaloge, Suzette
    ONCOLOGIST, 2011, 16 (09): : 1250 - 1257
  • [40] Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations
    Casey, MJ
    Synder, C
    Bewtra, C
    Narod, SA
    Watson, P
    Lynch, HT
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 457 - 467